These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9044802)

  • 1. Pharmacists' beliefs about abortion and RU-486.
    Giannetti V
    J Am Pharm Assoc (Wash); 1996 Dec; NS36(12):698-703. PubMed ID: 9044802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do pharmacists have a right to refuse to fill prescriptions for abortifacient drugs?
    Weinstein BD
    Law Med Health Care; 1992; 20(3):220-3. PubMed ID: 1434764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. British community pharmacists' views of physician-assisted suicide (PAS).
    Hanlon TR; Weiss MC; Rees J
    J Med Ethics; 2000 Oct; 26(5):363-9. PubMed ID: 11055040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Listening and learning from women about mifepristone: implications for counseling and health education.
    Castle MA; Harvey SM; Beckman L; Coeytaux F; Garrity JM
    Womens Health Issues; 1995; 5(3):130-8. PubMed ID: 7549491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Religion and conscientious objection: a survey of pharmacists' willingness to dispense medications.
    Davidson LA; Pettis CT; Joiner AJ; Cook DM; Klugman CM
    Soc Sci Med; 2010 Jul; 71(1):161-5. PubMed ID: 20447746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraguayan pharmacies and the sale of pseudo-abortifacients.
    Krayacich de Oddone N; Shedlin MG; Welsh M; Potts M; Feldblum P
    J Biosoc Sci; 1991 Apr; 23(2):201-9. PubMed ID: 2061347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
    Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
    Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprogestin drugs: ethical, legal and medical issues.
    Cook RJ; Grimes DA
    Law Med Health Care; 1992; 20(3):149-53. PubMed ID: 1434754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring influences on pharmacists' and students' ethical reasoning in a changing practice landscape in Australia.
    Sim TF; Sunderland B; Hattingh HL
    Int J Clin Pharm; 2019 Feb; 41(1):280-288. PubMed ID: 30578471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
    Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
    J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation.
    Munro S; Wahl K; Soon JA; Guilbert E; Wilcox ES; Leduc-Robert G; Ansari N; Devane C; Norman WV
    Implement Sci; 2021 Aug; 16(1):76. PubMed ID: 34344393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Death was a blessing"--should it ever be pharmaceutically hastened? British pharmacists' views.
    Hackett EA; Francis SA
    Pharm World Sci; 2003 Dec; 25(6):288-93. PubMed ID: 14689818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.
    Zusman EZ; Munro S; Norman WV; Soon JA
    BMJ Open; 2022 Oct; 12(10):e063370. PubMed ID: 36207038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and attitudes of community pharmacists toward professional ethics and ethical dilemmas in the workplace.
    Vuković Rodríguez J; Juričić Ž
    Res Social Adm Pharm; 2018 May; 14(5):441-450. PubMed ID: 28551410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes on the ethics of abortion, sex selection, and selective pregnancy termination among health care professionals, ethicists, and clergy likely to encounter such situations.
    Evans MI; Drugan A; Bottoms SF; Platt LD; Rodeck CA; Hansmann M; Fletcher JC
    Am J Obstet Gynecol; 1991 Apr; 164(4):1092-9. PubMed ID: 2014831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
    Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
    J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortion: epidemiology, safety, and technique.
    Blumenthal PD
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):506-12. PubMed ID: 1504270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' concerns and perceived benefits from the deregulation of hormonal emergency contraception (HEC).
    Blackwell D; Cooper N; Taylor G; Holden K
    Br J Fam Plann; 1999 Oct; 25(3):100-4. PubMed ID: 10567059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.